Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

Clinical trial NCT05172050 · COMPLETED

Trial details

NCT number: NCT05172050
Sponsor: Dompé Farmaceutici S.p.A
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS CoV 2 Infection

Start date: 2021-01-22
Primary completion: 2021-06-12
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.